Showing results (141-150 of 1,186) with videos related to
Sort By:
Pageof 119
Pharmaceutical Statistics|December 1, 2011
Recommendations on the statistical analysis of the Comet assayJonathan Bright, Mike Aylott, Simon Bate, et al.Pharmaceutical Statistics|December 6, 2011
Investigating the assumption of homogeneity of treatment effects in clinical studies with application to meta-analysisSteven A Julious, Anne WhiteheadPharmaceutical Statistics|January 11, 2012
Multiple comparisons to both a negative and a positive controlMario HaslerPharmaceutical Statistics|January 11, 2012
An examination of the relative impact of type I and type II error rates in phase II drug screening trial queuesAlan D Hutson, Gregory E WildingPharmaceutical Statistics|February 14, 2012
Block response-adaptive randomization in clinical trials with binary endpointsDominic MagirrPharmaceutical Statistics|February 14, 2012
An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpointsMartin Jenkins, Andrew Stone, Christopher JennisonPharmaceutical Statistics|March 17, 2012
Stability criteria for the outcomes of statistical tests to assess drug effectiveness with a single studyDaniele De MartiniPharmaceutical Statistics|March 14, 2012
Escalation strategies for combination therapy Phase I trialsMichael J Sweeting, Adrian P ManderPharmaceutical Statistics|March 14, 2012
Prediction of accrual closure date in multi-center clinical trials with discrete-time Poisson process modelsGong Tang, Yuan Kong, Chung-Chou Ho Chang, et al.Pharmaceutical Statistics|March 14, 2012
Propensity score applied to survival data analysis through proportional hazards models: a Monte Carlo studyEtienne Gayat, Matthieu Resche-Rigon, Jean-Yves Mary, et al.Pageof 119